See also this year's filing and all EDGAR filings for this company.
PDF Report 0001590750_2021_Viridian_Therapeutics_Inc_DE.pdf
Logs
Graph
Absolute values for 0001590750, Viridian Therapeutics Inc.\DE
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 1,335,000 |
| 2 | AssetsCurrent | 129,611,000 |
| 3 | PropertyPlantAndEquipment | 309,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 544,000 |
| 6 | LiabilitiesCurrent | 10,674,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 13,265,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 98,673,000 |
| 17 | remainder_Revenues | 1,050,000 |
| 18 | remainder_NetIncome | 173,000 |
| 19 | remainder_ComprehensiveNetIncome | -8,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 131,255,000 |
| 1 | Liabilities | 11,218,000 |
| 2 | Expenses | 111,938,000 |
| 3 | Revenues | 1,050,000 |
| 4 | StockholdersEquity | 120,037,000 |
| 5 | NetIncome | -110,715,000 |
| 6 | ComprehensiveNetIncome | -110,723,000 |
| 7 | BaseVar | 146,493,885 |
| 8 | EconomicCapitalRatio | 0.781 |
Edgar->Model Mapping
Feature Distribution
Change over Time
